- Home
- SAM vs ARWR Comparison
SAM vs ARWR Comparison
Compare SAM & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAM
- ARWR
- Stock Information
- Founded
- SAM 1984
- ARWR 2003
- Country
- SAM United States
- ARWR United States
- Employees
- SAM N/A
- ARWR N/A
- Industry
- SAM Beverages (Production/Distribution)
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- SAM Consumer Staples
- ARWR Health Care
- Exchange
- SAM Nasdaq
- ARWR Nasdaq
- Market Cap
- SAM 2.7B
- ARWR 2.5B
- IPO Year
- SAM 1995
- ARWR 1993
- Fundamental
- Price
- SAM $239.12
- ARWR $13.82
- Analyst Decision
- SAM Hold
- ARWR Buy
- Analyst Count
- SAM 10
- ARWR 11
- Target Price
- SAM $289.44
- ARWR $41.44
- AVG Volume (30 Days)
- SAM 220.4K
- ARWR 1.6M
- Earning Date
- SAM 04-24-2025
- ARWR 05-08-2025
- Dividend Yield
- SAM N/A
- ARWR N/A
- EPS Growth
- SAM N/A
- ARWR N/A
- EPS
- SAM 5.06
- ARWR N/A
- Revenue
- SAM $2,012,926,000.00
- ARWR $2,500,000.00
- Revenue This Year
- SAM $2.79
- ARWR $4,380.43
- Revenue Next Year
- SAM $2.95
- ARWR $59.62
- P/E Ratio
- SAM $47.29
- ARWR N/A
- Revenue Growth
- SAM 0.21
- ARWR N/A
- 52 Week Low
- SAM $215.10
- ARWR $13.66
- 52 Week High
- SAM $339.77
- ARWR $30.41
- Technical
- Relative Strength Index (RSI)
- SAM 53.78
- ARWR 31.81
- Support Level
- SAM $215.10
- ARWR $14.69
- Resistance Level
- SAM $231.31
- ARWR $15.65
- Average True Range (ATR)
- SAM 6.76
- ARWR 0.79
- MACD
- SAM 2.05
- ARWR -0.07
- Stochastic Oscillator
- SAM 86.36
- ARWR 6.00
About SAM Boston Beer Company Inc. (The)
Boston Beer is a top player in high-end malt beverages and adjacent categories in the us, with strong positions in craft beer, flavored malt beverages, hard cider, and hard seltzer. The bulk of volume and revenue is concentrated in four brands: Samuel Adams, Angry Orchard, Twisted Tea, and Truly. Beverages are produced using a hybrid model leveraging both in-house capacities and third-party breweries through contract arrangements. While the firm is required to use distributors to reach end markets, including retailers and on-premises operators, it also employs 500 internal sales representatives to educate the market about its products. The firm generates over 95% of sales in the us.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.